BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7745465)

  • 1. Treatment of thromboembolic complications in patients with brain tumors.
    Norris LK; Grossman SA
    J Neurooncol; 1994; 22(2):127-37. PubMed ID: 7745465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
    Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolic disease in cancer patients.
    Hindi N; Cordero N; Espinosa E
    Support Care Cancer; 2013 May; 21(5):1481-6. PubMed ID: 23430009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.
    Carter BL; Jones ME; Waickman LA
    Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of acute thromboembolism with heparin and warfarin.
    Carter BL
    Clin Pharm; 1991 Jul; 10(7):503-18. PubMed ID: 1860301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and treatment of venous thromboembolism.
    Pineo GF; Hull RD
    Drugs; 1996 Jul; 52(1):71-92. PubMed ID: 8799686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk and efficacy of anticoagulant therapy in the treatment of thromboembolic complications in patients with primary malignant brain tumors.
    Altschuler E; Moosa H; Selker RG; Vertosick FT
    Neurosurgery; 1990 Jul; 27(1):74-6; discussion 77. PubMed ID: 2377284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of antithrombotic drugs in older people.
    Tufano A; Cerbone AM; Di Minno G
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic drugs: part I.
    Gallus AS; Hirsh J
    Drugs; 1976; 12(1):41-68. PubMed ID: 789043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.
    Colwell CW; Collis DK; Paulson R; McCutchen JW; Bigler GT; Lutz S; Hardwick ME
    J Bone Joint Surg Am; 1999 Jul; 81(7):932-40. PubMed ID: 10428124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home parenteral nutrition-associated thromboembolic and bleeding events: results of a cohort study of 236 individuals.
    Barco S; Heuschen CB; Salman B; Brekelmans MP; Serlie MJ; Middeldorp S; Coppens M
    J Thromb Haemost; 2016 Jul; 14(7):1364-73. PubMed ID: 27122107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of anticoagulant therapy.
    Deykin D
    Am J Med; 1982 Apr; 72(4):659-64. PubMed ID: 7072746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulants in pregnancy.
    Howie PW
    Clin Obstet Gynaecol; 1986 Jun; 13(2):349-63. PubMed ID: 2426029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
    Brekelmans MP; Ageno W; Beenen LF; Brenner B; Buller HR; Chen CZ; Cohen AT; Grosso MA; Meyer G; Raskob G; Segers A; Vanassche T; Verhamme P; Wells PS; Zhang G; Weitz JI
    Lancet Haematol; 2016 Sep; 3(9):e437-45. PubMed ID: 27570090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
    Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
    J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding and thrombotic events occur early in children on durable ventricular assist devices.
    Huang JY; Ignjatovic V; Sheridan BJ; Mathew J; D'Udekem Y; Brink J; Barton R; Callea G; Morsman D; Donath S; Opat S; Monagle P
    Thromb Res; 2019 Jan; 173():65-70. PubMed ID: 30476715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic drugs for older subjects. Guidelines formulated jointly by the Italian Societies of Haemostasis and Thrombosis (SISET) and of Gerontology and Geriatrics (SIGG).
    Di Minno G; Tufano A; Cerbone AM
    Nutr Metab Cardiovasc Dis; 2001 Feb; 11(1):41-62. PubMed ID: 11383324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.
    Decousus H; Leizorovicz A; Parent F; Page Y; Tardy B; Girard P; Laporte S; Faivre R; Charbonnier B; Barral FG; Huet Y; Simonneau G
    N Engl J Med; 1998 Feb; 338(7):409-15. PubMed ID: 9459643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.